Musculoskeletal Diseases: News and Research on Spondylarthritis

MeSH tree: C05.550.114.865

FDA approves Bimzelx for three new indications

The U.S. Food and Drug Administration has approved Bimzelx (bimekizumab-bkzx) for the treatment of adults with active psoriatic arthritis (PsA), adults with active nonradiographic axial spondyloarthritis (nr-axSpA) with objective ...

page 3 from 10